Drugs / Campt, Topotesin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00209612 | Apr 2004 → Nov 2008 | gastric cancer | Hokkaido Gastrointestinal Cancer Study Group | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Campt, Topotesin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00209612 ↗ |
| Route | Intravenous | “Day1,15 Y mg/m2, IV (in the vein)” NCT00209612 ↗ |